ABVC BIOPHARMA INC ABVC
COM NEW · Common Stock · CUSIP 00091F304
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersFremont, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.23.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 10 |
| Q4 2023 | 9 |
| Q1 2024 | 9 |
| Q2 2024 | 12 |
| Q3 2024 | 10 |
| Q4 2024 | 14 |
| Q1 2025 | 11 |
| Q2 2025 | 10 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 4 | 3 |
| Q1 2024 | 6 | 2 |
| Q2 2024 | 7 | 3 |
| Q3 2024 | 3 | 4 |
| Q4 2024 | 8 | 1 |
| Q1 2025 | 5 | 5 |
| Q2 2025 | 6 | 4 |
Biggest buyers
| VANGUARD GROUP INC | Added | +64.6k |
| RENAISSANCE TECHNOLOGIES LLC | New | +41.7k |
| NORTHERN TRUST CORP | Added | +18.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +6.0k |
| BANK OF AMERICA CORP /DE/ | Added | +48 |
| SBI Securities Co., Ltd. | Added | +23 |
Biggest sellers
| UBS Group AG | Sold out | -29.0k |
| TWO SIGMA SECURITIES, LLC | Sold out | -11.5k |
| XTX Topco Ltd | Reduced | -7.8k |
| Tower Research Capital LLC (TRC) | Reduced | -2.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Jiang Eugene
13D · may seek influence
+1.1 pts · filed 2025-07-15
Stated purposeCertain of the Issuer's shareholders sought to grant the Reporting Person voting rights with respect to such shareholder's shares. Full filing |
18.5% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| VANGUARD GROUP INC 0.00% of their portfolio | 111.5k $248.2k | Added +64.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 110.5k $245.9k | Added +6.0k |
| XTX Topco Ltd 0.00% of their portfolio | 52.6k $117.1k | Reduced -7.8k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 41.7k $92.8k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 37.1k $82.6k | Added +18.0k |
| STATE STREET CORP 0.00% of their portfolio | 12.9k $28.7k | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 483 $1.1k | Added +23 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 354 $788 | Reduced -2.2k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 133 $296 | Added +48 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |